Boehringer Ingelheim reported modest first-half 2026 growth in its Animal Health business while advancing new product launches, expanding AI-enabled diagnostics, and supporting responses to emerging livestock disease outbreaks.
A new global survey from Boehringer Ingelheim found that veterinarians believe many of the most important parts of their work — including disease detection, food safety, and public health protection — often go unnoticed by the public.
A new AI-powered auscultation solution aims to help veterinarians detect and grade canine heart murmurs earlier, improving diagnosis and treatment outcomes.
Boehringer Ingelheim and the Atlanta Braves are bringing back “The Dogout” for 2026, highlighting veterinary professionals and their impact on pet health.
Authorization allows veterinarians to use NexGard® and NexGard® COMBO to treat New World screwworm infestations amid spread in Mexico.
The U.S. FDA has granted an Emergency Use Authorization for IVOMEC® (ivermectin) 1% Injection, marking the first over-the-counter product authorized to help prevent New World screwworm infestations in cattle amid heightened regional surveillance concerns.
The FDA has granted full approval for Vetmedin (pimobendan) to delay the onset of congestive heart failure in dogs with preclinical myxomatous mitral valve disease—the first animal drug indication to transition from expanded conditional to full approval.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.